Before Janet Rowley, few scientists suspected that chromosomal aberrations caused cancer. Beginning in the 1970s, however, she made a series of fundamental discoveries demonstrating that specific chromosomal changes caused certain types of leukemia.
An argument can be made that only a government research agency like NCI has the capacity to answer questions about monitoring pancreatic cysts—and how some of them turn malignant.
Prevention and early detection trials have been especially vulnerable to being disrupted by the COVID-19 lockdown, and a comparison of two regimens for monitoring pancreatic cysts—EA2185—was more vulnerable than most.
Prevention and early detection studies frequently require engaging physicians from specialties other than oncologists, said Peter O’Dwyer and Mitchell Schnall, co-chairs of ECOG-ACRIN Cancer Research Group.
Vinay Prasad might well have made his contrarian points without invoking the specter of the Third Reich. He didn’t have to go there—but he did. Voluntarily.
There is reason for concern about fascism rising in the United States. The reason is primarily Trumpism, followed by racism, followed by right-wing seditionist impulses.
Francis Collins will step down as director of NIH by the end of 2021, closing out a chapter in his career as the longest-serving presidentially appointed NIH director.
Thomas A. Waldmann, chief emeritus of the NCI Lymphoid Malignancies Branch and NIH Distinguished Investigator, died Sept. 25. He was 91.
Emil J Freireich, a trailblazing oncologist who developed groundbreaking therapies for childhood leukemia, and one of the 60 original members of ASCO, died Feb. 1.
American cancer patients have collectively gained up to 14 million years of life since 1980 as a result of NCI-funded cancer trials conducted by the National Clinical Trials Network, a study led by SWOG Cancer Research Network found.
